We are proud to announce RC REDOL’s participation at the 1st INTERNATIONAL DAYS OF GENERIC DRUGS AND BIOSIMILARIES, organised by the Tunisian Association of Generic Medicines – ATMG and which will take place on 17 and 18 May 2024, at the Palais du Congrès in Tunis, Tunisia.
This innovative event, organised in partnership with the Tunisian Ministry of Health, promises to be a milestone for the pharmaceutical sector, both locally and internationally.
Reasons not to miss this unique event:
– First edition in Tunisia: a historic moment for the country, underlining its growing role in the global pharmaceutical industry.
– Meeting suppliers and experts: a unique opportunity to interact with suppliers of raw materials, services and cutting-edge technologies.
– Participation of local and international manufacturers: meet the leading generic manufacturers who are shaping the future of the sector.
– Presence of official authorities: authorities from several African countries will be present, providing an essential regulatory perspective.
– Extensive exhibition: a chance to explore the latest technologies, pharmaceutical raw materials, services, machinery, and obtain information from GMP and legal experts.
– Networking opportunity: the ideal environment to cooperate and find new business and strategic partners.
The conference will also host interesting lectures and debates on key industry issues, with several key themes:
– Sector regulations
– Development challenges and opportunities
– From raw materials to finished products
– Application of artificial intelligence and Industry 4.0
– Cooperation and integration in Africa
This event represents an incredible opportunity for pharmaceutical industry professionals to connect, learn and collaborate. Whether it’s building partnerships, expanding your knowledge of trends and innovations, or simply being at the forefront of the pharmaceutical industry, ATMG’s International Generic and Biosimilar Days is the place to be.
Mark your diary and join us on this innovative journey. We look forward to seeing how, together, we can shape the future of global health.